See more : Goldwin Inc. (8111.T) Income Statement Analysis – Financial Results
Complete financial analysis of Agentix Corp. (AGTX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Agentix Corp., a leading company in the Biotechnology industry within the Healthcare sector.
- Doosan Corporation (000150.KS) Income Statement Analysis – Financial Results
- Yantai Eddie Precision Machinery Co., Ltd. (603638.SS) Income Statement Analysis – Financial Results
- SEPC Limited (SEPC.BO) Income Statement Analysis – Financial Results
- Acuity RM Group Plc Ord (ACRM.L) Income Statement Analysis – Financial Results
- Flat Glass Group Co., Ltd. (6865.HK) Income Statement Analysis – Financial Results
Agentix Corp. (AGTX)
About Agentix Corp.
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.
| Metric | 2023 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 1.24K | 0.00 | 0.00 | 2.25K | 43.14K | 28.38K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 561.00 | 0.00 | 0.00 | 1.36K | 1.36K | 2.04K | 0.00 | 0.00 |
| Gross Profit | 0.00 | 679.00 | 0.00 | 0.00 | 893.00 | 41.79K | 26.34K | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 54.76% | 0.00% | 0.00% | 39.69% | 96.85% | 92.82% | 0.00% | 0.00% |
| Research & Development | 711.51K | 365.13K | 0.00 | 0.00 | 0.00 | 3.69K | 28.33K | 61.75K | 10.00K |
| General & Administrative | 660.25K | 975.90K | 121.32K | 134.38K | 334.88K | 330.53K | 173.14K | 147.13K | 40.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 660.25K | 975.90K | 121.32K | 134.38K | 334.88K | 330.53K | 173.14K | 147.13K | 40.00K |
| Other Expenses | 0.00 | 227.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.37M | 1.34M | 121.32K | 134.38K | 334.88K | 334.22K | 201.47K | 208.88K | 50.00K |
| Cost & Expenses | 1.37M | 1.34M | 121.32K | 134.38K | 336.24K | 335.58K | 203.50K | 208.88K | 50.00K |
| Interest Income | 0.00 | 5.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.64K | 19.52K | 11.34K | 24.82K | 13.34K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 19.95K | -19.52K | 140.00 | 264.00 | 264.00 | 453.00 | 387.00 | 429.00 | 0.00 |
| EBITDA | -1.37M | -1.34M | -121.18K | -134.11K | -333.73K | -291.98K | -174.74K | -208.45K | -50.00K |
| EBITDA Ratio | 0.00% | -108,092.90% | 0.00% | 0.00% | -14,832.27% | -676.77% | -615.82% | 0.00% | 0.00% |
| Operating Income | -1.37M | -1.34M | -121.32K | -134.38K | -333.99K | -292.43K | -175.13K | -208.88K | -50.00K |
| Operating Income Ratio | 0.00% | -108,147.66% | 0.00% | 0.00% | -14,844.00% | -677.82% | -617.18% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.05K | -19.52K | -11.34K | -42.65M | -47.11K | -3.21K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.37M | -1.34M | -132.65K | -42.79M | -381.10K | -295.64K | -175.13K | -208.88K | -50.00K |
| Income Before Tax Ratio | 0.00% | -108,092.50% | 0.00% | 0.00% | -16,937.82% | -685.25% | -617.18% | 0.00% | 0.00% |
| Income Tax Expense | 406.00 | 19.52K | 11.34K | 42.63M | 33.77K | 3.21K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.37M | -1.34M | -143.99K | -85.42M | -414.87K | -298.84K | -175.13K | -208.88K | -50.00K |
| Net Income Ratio | 0.00% | -108,092.50% | 0.00% | 0.00% | -18,438.71% | -692.68% | -617.18% | 0.00% | 0.00% |
| EPS | -0.04 | -0.39 | -0.07 | -7.74K | -68.95 | -49.65 | -29.39 | -38.05 | -5.00 |
| EPS Diluted | -0.04 | -0.39 | -0.07 | -7.74K | -68.95 | -49.65 | -29.39 | -38.05 | -5.00 |
| Weighted Avg Shares Out | 39.23M | 3.42M | 2.06M | 11.04K | 6.02K | 6.02K | 5.96K | 5.49K | 10.00K |
| Weighted Avg Shares Out (Dil) | 39.23M | 3.42M | 2.06M | 11.04K | 6.02K | 6.02K | 5.96K | 5.49K | 10.00K |
Source: https://incomestatements.info
Category: Stock Reports